Bellucci S. Autoimmune thrombocytopenias. Baillière's Clin Haematol 1989; 2: 695-718.
Harrington WJ, Minnich V, Hollingsworth PJ, Moore CV. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 1951; 38: 1-9.
Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet reactive antibodies. Blood 1987; 70: 1722-1726.
Kokawa T, Nomura S, Yanabu M, Yasunaga K. Detection of platelet antigen for platelet antibodies in idiopathic thrombocytopenic purpura by flow cytometry, antigen capture ELISA and immunobloting: a comparative study. Eur J Hematol 1993; 5C: 74-80.
Deckmyn H, de Reys S. Functional effects of human antiplatelet antibodies. Semin Thromb Hemost 1995; 21: 46-59.
Bellavite P, Andrioli G, Guzzo P, et al. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem 1994; 216: 444-450.
Di Fazio LT, Stratoulias C, Greco RS, Haimovich B. Multiple surface receptors mediate platelet adhesion to surfaces coated with plasma proteins. J Surg Res 1994; 57: 133-137.
Nagai H, Handa M, Kawai Y, Watanabe K, Ikeda Y. Evidence that plasma fibrinogen and platelet membrane GPIIb/IIIa are involved in the adhesion of platelets to an artificial surface exposed to plasma. Thromb Res 1993; 71: 467-477.
Baumgartner HR, Muggli R, Tschopp TB, Turitto T. Platelet adhesion, release and aggregation in flowing blood: effects of surface properties and platelet function. Thromb Haemost 1976; 35: 124-138.
Sakariassen KS, Aarts PAMM, de Groot PG, Houdijk WPM, Sixma JJ. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med 1983; 102: 522-535.
Vroman L, Adams AL. Identification of rapid changes at plasma-solid interfaces. J Biomed Mater Res 1969; 3: 43-67.
Vroman L. The life of an artificial device in contact with blood: initial events and their effects on its final state. Bull NY Acad Med 1988; 64: 352-357.
Deckmyn H, Stanssens P, Hoet B, et al. An echistatin-like Arg-Gly-Asp(RGD)-containing sequence in the heavy chain CDR3 of a murine monoclonal antibody that inhibits human platelet glycoprotein GPIIb/IIIa function, Br J Haematol 1994; 87: 562-571.
Berchtold P, Dale GL, Tani P, McMillan R. Inhibition of autoantibody binding to platelet glycoprotein IIb/ IIIa by antiidiotypic antibodies in intravenous gamma-globulin. Blood 1989; 74: 2414-2417.
Slack SM, Weiss HJ, Lages B, Turitto VT. Mathematical analysis of bleeding time data in patients with platelet disorders and von Willebrand's disease. Platelets 1995; 6: 169-175.
Berchtold P, Wenger M. Autoantibodies against platelet glycoprotein in autoimmune thrombocytopenic purpura: their clinical significance and response to treatment. Blood 1993; 81: 1246-1250.
Savage B, Saldivar K, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-297.
